Table 1 Characteristics of the study participants according to serum parathyroid hormone levels.

From: Unraveling the relationship between serum parathyroid hormone levels and trabecular bone score: a cross-sectional study

Characteristics

 

PTH levels (pmol/L)

P Value

 

Q1 (0.70–3.41)

Q2 (3.41–4.51)

Q3 (4.51–5.83)

Q4 (5.83–54.01)

Age

 

40.84 ± 14.53

45.59 ± 15.49

49.55 ± 16.22

52.68 ± 16.55

 < 0.0001

Gender

Male

464 (56.59%)

498 (54.37%)

430 (50.00%)

438 (47.61%)

 < 0.0001

 

Female

356 (43.41%)

418 (45.63%)

430 (50.00%)

482 (52.39%)

 

Race/ethnicity (%)

 < 0.0001

 

Non-Hispanic White

484 (59.02%)

471 (51.42%)

440 (51.16%)

415 (45.11%)

 
 

Non-Hispanic Black

141 (17.20%)

177 (19.32%)

175 (20.35%)

275 (29.89%)

 
 

Mexican American

149 (18.17%)

193 (21.07%)

188 (21.86%)

174 (18.91%)

 
 

Other Race

46 (5.61%)

75 (8.19%)

57 (6.63%)

56 (6.09%)

 

PIR

 

2.73 ± 1.57

2.83 ± 1.69

2.75 ± 1.59

2.69 ± 1.57

0.426

BMI

 

26.86 ± 5.25

27.66 ± 5.33

28.67 ± 5.76

29.73 ± 6.26

 < 0.001

Total spine BMD, gm/cm2

 

1.05 ± 0.14

1.04 ± 0.15

1.03 ± 0.15

1.03 ± 0.17

0.038

TBS

 

1.42 ± 0.13

1.39 ± 0.14

1.36 ± 0.14

1.33 ± 0.15

 < 0.001

Alkaline phosphatase, mg/dl

 

66.45 ± 24.90

70.30 ± 24.35

70.44 ± 22.05

77.71 ± 31.85

 < 0.001

Blood urea nitrogen, mg/dl

 

12.22 ± 4.61

12.45 ± 4.43

12.93 ± 4.96

14.33 ± 7.76

 < 0.001

Total cholesterol, mg/dl

 

198.86 ± 41.92

198.93 ± 40.85

201.13 ± 45.36

197.89 ± 40.65

0.429

Total protein, mg/dl

 

7.15 ± 0.47

7.19 ± 0.50

7.13 ± 0.44

7.12 ± 0.47

0.014

Serum uric acid, mg/dl

 

5.20 ± 1.28

5.35 ± 1.34

5.43 ± 1.33

5.72 ± 1.55

 < 0.001

Calcium, mg/dl

 

9.60 ± 0.33

9.53 ± 0.32

9.47 ± 0.31

9.42 ± 0.42

 < 0.0001

Creatinine, mg/dl

 

0.92 ± 0.19

0.92 ± 0.21

0.93 ± 0.20

1.07 ± 0.78

 < 0.0001

Phosphorus, mg/dl

 

3.88 ± 0.57

3.83 ± 0.55

3.76 ± 0.53

3.72 ± 0.58

 < 0.0001

HDL-C, mg/dl

 

54.13 ± 16.67

53.34 ± 15.28

54.25 ± 16.19

54.50 ± 16.52

0.758

LDL-C, mg/dl

 

116.97 ± 37.46

116.86 ± 35.92

119.42 ± 38.99

114.72 ± 37.29

0.147

CRP, mg/dl

 

0.39 ± 1.07

0.41 ± 0.71

0.41 ± 0.69

0.50 ± 0.69

 < 0.0001

Vit D, mg/dl

 

64.30 ± 21.16

58.30 ± 20.04

54.97 ± 18.53

50.21 ± 19.03

 < 0.0001

Alcohol

Yes

98 (11.95%)

147 (16.05%)

147 (17.09%)

174 (18.91%)

 < 0.0001

 

No

68 (8.29%)

105 (11.46%)

120 (13.95%)

134 (14.57%)

 
 

Missing

654 (79.76%)

664 (72.49%)

593 (68.95%)

612 (66.52%)

 

Coronary heart disease

Yes

17 (2.07%)

20 (2.18%)

37 (4.30%)

56 (6.09%)

 < 0.0001

 

No

800 (97.56%)

895 (97.71%)

820 (95.35%)

855 (92.93%)

 
 

Missing

3 (0.37%)

1 (0.11%)

3 (0.35%)

9 (0.98%)

 

Physical activity

Yes

362 (44.15%)

391 (42.69%)

354 (41.16%)

383 (41.63%)

 < 0.0001

 

No

210 (25.61%)

196 (21.40%)

172 (20.00%)

149 (16.20%)

 
 

Missing

248 (30.24%)

329 (35.92%)

334 (38.84%)

388 (42.17%)

 

Cancer

Yes

47 (5.73%)

74 (8.08%)

80 (9.30%)

95 (10.33%)

0.012

 

No

773 (94.27%)

840 (91.70%)

780 (90.70%)

824 (89.57%)

 
 

Missing

0 (0.00%)

2 (0.22%)

0 (0.00%)

1 (0.11%)

 

Smoking

Yes

467 (56.95%)

453 (49.45%)

401 (46.63%)

409 (44.46%)

 < 0.0001

 

No

351 (42.80%)

463 (50.55%)

459 (53.37%)

511 (55.54%)

 
 

Missing

2 (0.24%)

0 (0.00%)

0 (0.00%)

0 (0.00%)

 
  1. Data are expressed as weighted means ± SD or percentages (%).
  2. PIR, poverty income ratio; BMI, body mass index; BMD, bone mineral density; TBS, trabecular bone score; HDL-C (high-density lipoprotein cholesterol), LDL-C (low density lipoprotein-cholesterol), CRP (C-reactive protein).
  3. Q1: 0.70 pmol/L ≤ PTH levels ≤ 3.41 pmol/L; Q2: 3.41 pmol/L < PTH levels ≤ 4.51 pmol/L; Q3: 4.51 pmol/L < PTH levels ≤ 5.83 pmol/L; Q4: 5.83 pmol/L < PTH levels ≤ 54.01 pmol/L.